Three patients are presented in whom TD either disappeared (2 cases) or improved (one case) after discontinuing antiparkinsonian medication without changing the concurrent neuroleptic treatment. In addition, two of the patients presented some “complications” secondary to the TD in the form of frequent falling, psychosocial impairment and suicidal ruminations. The implications of these findings are discussed in the light of the current literature.
References
1.
MackayA.V.P., SheppardG.P.Pharmacotherapeutic trials in tardive dyskinesia.Br J Psychiatry1979; 135: 489–499.
2.
KilohL.G., SmithJ.S., WilliamsS.E.Antiparkinson drugs as causal agents in tardive dyskinesia.Med J Aust1973; 2: 591–593.
TurekI., KurrlandA.A., HanlonT.E.. Tardive dyskinesia: its relation to neuroleptic and antiparkinson drugs.Br J Psychiatry1972; 121: 605–612.
5.
GerlachJ., ThorsenK.The movement pattern of oral tardive dyskinesia in relation to anticholinergic and anti-dopaminergic treatment.Int Pharmacopsychiat1976; 11: 1–7.
6.
GoodM.I.Reversibility of long-term tardive dyskinesia associated with antiparkinsonian medication: a case report.Am J Psychiatry1981; 138: 1112–1113.
7.
DavisJ.M.Dose equivalence of the antipsychotic drugs. In: MatthysseS.S., KetyS.S., eds. Catecholamines and their enzymes in the neuropathology of schizophrenia.Elmsford, NY.: Pergamon Press, 1974: 59–65.
8.
TarsyD.Dopamine-acetylcholine interaction in the basal ganglia. In: FieldS.W., ed. Neurotransmitter function.New York: Grune and Stratton, 1976.
MooreD.C., BowersM.B.Identification of a subgroup of tardive dyskinesia patients by pharmacologic probes.Am J Psychiatry1980; 137: 1202–1205.
11.
GardosG., ColeJ.O.Tardive dyskinesia and anticholinergic drugs.Am J Psychiatry1983; 140: 200–202.
12.
ManosN., GkiouzepasJ., LogothetisJ.The need for continuous use of antiparkinsonian medication with chronic schizophrenic patients receiving long-term neuroleptic therapy.Am J Psychiatry1981; 138: 184–188.
13.
ManosN., GkouzepasJ., TzotzorasT.. Gradual withdrawal of antiparkinsonian medication in chronic schizophrenics: any better than the abrupt?J Nerv Ment Dis1981; 169: 659–661.
14.
ChouinardG., AnnableL., Ross-ChouinardA.Fluphenazine enanthate and fluphenazine decanoate in the treatment of schizophrenic outpatients: extrapyramidal symptoms and therapeutic effect.Am J Psychiatry1982; 139: 312–318.
15.
JesteD.V., JesteS.D., WyattR.J.Reversible tardive dyskinesia: implications for therapeutic strategy and prevention of tardive dyskinesia.Mod Probl Pharmacopsychiat1983; 21: 34–48.
16.
QuitkinF., RifkinA., GochfeldL.. Tardive dyskinesia: are first signs reversible?Am J Psychiatry1977; 134: 84–87.
17.
AlpertM., DiamondF., FriedhoffA.J.Tremographic studies in tardive dyskinesia.Psychopharmacol Bull1976; 12: 5–7.
18.
RosenbaumA.M., NivenR.G., HansonN.P.. Tardive dyskinesia: relationship with a primary affective disorder.Dis Nerv Syst1977; 38: 423–427.
19.
YassaR., GhadirianA.M., SchwartzG.Prevalence of tardive dyskinesia in affective disorders.J Clin Psychiatry1983; 44: 410–412.
20.
YassaR., SchwartzG.Depression as a predictor in the development of tardive dyskinesia.Biol Psychiatry1984; 19: 441–444.
21.
YassaR., JonesB.D.The complications of tardive dyskinesia: a review.Psychosomatics1985; 26: 305–313.
22.
TarsyD., GranacherR., BralowerM.Tardive dyskinesia in young adults.Am J Psychiatry1977; 134: 1032–1034.
HunterR., EarlC.J., ThornicroftS.An apparently irreversible syndrome of abnormal movements following pheno-thiazine medication.Proc Roy Soc Med1964; 57: 758–762.
25.
SimpsonG.M., ShrivastavaR.K.Abnormal gaits in tardive dyskinesia.Am J Psychiatry1978; 135: 865.
26.
WeinerW.J., GoetzC.G., NausiedaP.A.. Respiratory dyskinesias: extrapyramidal dysfunction and dyspnea.Ann Int Med1978; 88: 327–331.
27.
FreedE.Tardive dyskinesia. Subjective discomfort from psychosocial stress.South African Med J1982; 62: 80.
28.
ChouinardG., BoisvertD., BradwejnJ.Tardive dyskinesia in a nonpsychiatric patient due to short-term use of a neuroleptic/anticholinergic combination drug.Can Med Assoc J1982; 126: 821–822.
